Cargando…
Failure of a single day metronidazole desensitization protocol, and success of a modified two-day protocol in an outpatient setting
BACKGROUND: True allergy to metronidazole, a common anti-infective in clinical practice, is rarely reported in the literature. In the case of Trichomonas, there are few alternatives to the nitrimidazole class of drugs, and the alternatives that do exist are associated with worse clinical outcomes. A...
Autores principales: | Cahill, Julia A., Sahota, Preena Simritpreet, Kan, Manstein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713436/ https://www.ncbi.nlm.nih.gov/pubmed/34963477 http://dx.doi.org/10.1186/s13223-021-00640-4 |
Ejemplares similares
-
Modified oral metronidazole desensitization protocol
por: Gendelman, Samantha R., et al.
Publicado: (2014) -
Successful olaparib desensitization using a novel one-day protocol
por: Zhu, Rongbo, et al.
Publicado: (2020) -
A successful protocol for desensitization to iron salts
por: Terzioğlu, Kadriye, et al.
Publicado: (2021) -
Successful Dabrafenib Desensitization Protocols in a Patient with Metastatic Melanoma
por: Bumbacea, Roxana Silvia, et al.
Publicado: (2022) -
Oral Metronidazole Desensitization for Immunoglobulin E (IgE)-Mediated Hypersensitivity
por: Hollis, Chantae C, et al.
Publicado: (2022)